304 related articles for article (PubMed ID: 36230805)
21. Liquid biopsies: DNA methylation analyses in circulating cell-free DNA.
Zeng H; He B; Yi C; Peng J
J Genet Genomics; 2018 Apr; 45(4):185-192. PubMed ID: 29706556
[TBL] [Abstract][Full Text] [Related]
22. Cell-free DNA and circulating tumor cell kinetics in a pre-clinical head and neck Cancer model undergoing radiation therapy.
Muhanna N; Eu D; Chan HHL; Douglas C; Townson JL; Di Grappa MA; Mohamadi RM; Kelley SO; Bratman SV; Irish JC
BMC Cancer; 2021 Oct; 21(1):1075. PubMed ID: 34600526
[TBL] [Abstract][Full Text] [Related]
23. Circulating Tumor DNA in Saliva in an Orthotopic Head and Neck Cancer Mouse Model.
Eun YG; Yoon YJ; Won KY; Lee YC
Anticancer Res; 2020 Jan; 40(1):191-199. PubMed ID: 31892567
[TBL] [Abstract][Full Text] [Related]
24. DNA methylation analysis of tumor suppressor genes in liquid biopsy components of early stage NSCLC: a promising tool for early detection.
Markou Α; Londra D; Tserpeli V; Kollias Ι; Tsaroucha E; Vamvakaris I; Potaris K; Pateras I; Kotsakis Α; Georgoulias V; Lianidou Ε
Clin Epigenetics; 2022 May; 14(1):61. PubMed ID: 35538556
[TBL] [Abstract][Full Text] [Related]
25. Combined multimodal ctDNA analysis and radiological imaging for tumor surveillance in Non-small cell lung cancer.
Metzenmacher M; Hegedüs B; Forster J; Schramm A; Horn PA; Klein CA; Bielefeld N; Ploenes T; Aigner C; Theegarten D; Schildhaus HU; Siveke JT; Schuler M; Lueong SS
Transl Oncol; 2022 Jan; 15(1):101279. PubMed ID: 34800919
[TBL] [Abstract][Full Text] [Related]
26. Towards precision medicine: advances in 5-hydroxymethylcytosine cancer biomarker discovery in liquid biopsy.
Zeng C; Stroup EK; Zhang Z; Chiu BC; Zhang W
Cancer Commun (Lond); 2019 Mar; 39(1):12. PubMed ID: 30922396
[TBL] [Abstract][Full Text] [Related]
27. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
[TBL] [Abstract][Full Text] [Related]
28. Cell-Free DNA as a Diagnostic Blood-Based Biomarker for Colorectal Cancer: A Systematic Review.
Petit J; Carroll G; Gould T; Pockney P; Dun M; Scott RJ
J Surg Res; 2019 Apr; 236():184-197. PubMed ID: 30694754
[TBL] [Abstract][Full Text] [Related]
29. Salivary Exosome and Cell-Free DNA for Cancer Detection.
Hyun KA; Gwak H; Lee J; Kwak B; Jung HI
Micromachines (Basel); 2018 Jul; 9(7):. PubMed ID: 30424273
[TBL] [Abstract][Full Text] [Related]
30. Review of the clinical applications and technological advances of circulating tumor DNA in cancer monitoring.
Chang Y; Tolani B; Nie X; Zhi X; Hu M; He B
Ther Clin Risk Manag; 2017; 13():1363-1374. PubMed ID: 29066904
[TBL] [Abstract][Full Text] [Related]
31. Methylation analyses in liquid biopsy.
Lissa D; Robles AI
Transl Lung Cancer Res; 2016 Oct; 5(5):492-504. PubMed ID: 27826530
[TBL] [Abstract][Full Text] [Related]
32. Liquid Biopsy in Head and Neck Cancer: Current Evidence and Future Perspective on Squamous Cell, Salivary Gland, Paranasal Sinus and Nasopharyngeal Cancers.
Cabezas-Camarero S; Pérez-Segura P
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740523
[TBL] [Abstract][Full Text] [Related]
33. Salivary HPV DNA informs locoregional disease status in advanced HPV-associated oropharyngeal cancer.
Hanna GJ; Lau CJ; Mahmood U; Supplee JG; Mogili AR; Haddad RI; Jänne PA; Paweletz CP
Oral Oncol; 2019 Aug; 95():120-126. PubMed ID: 31345379
[TBL] [Abstract][Full Text] [Related]
34. Circulating cell-free DNA for cancer early detection.
Gao Q; Zeng Q; Wang Z; Li C; Xu Y; Cui P; Zhu X; Lu H; Wang G; Cai S; Wang J; Fan J
Innovation (Camb); 2022 Jul; 3(4):100259. PubMed ID: 35647572
[TBL] [Abstract][Full Text] [Related]
35. A computational framework to unify orthogonal information in DNA methylation and copy number aberrations in cell-free DNA for early cancer detection.
Wei Q; Jin C; Wang Y; Guo S; Guo X; Liu X; An J; Xing J; Li B
Brief Bioinform; 2022 Jul; 23(4):. PubMed ID: 35649341
[TBL] [Abstract][Full Text] [Related]
36. Diagnosing and monitoring pancreatic cancer through cell-free DNA methylation: progress and prospects.
García-Ortiz MV; Cano-Ramírez P; Toledano-Fonseca M; Aranda E; Rodríguez-Ariza A
Biomark Res; 2023 Oct; 11(1):88. PubMed ID: 37798621
[TBL] [Abstract][Full Text] [Related]
37. Computational challenges in detection of cancer using cell-free DNA methylation.
Sharma M; Verma RK; Kumar S; Kumar V
Comput Struct Biotechnol J; 2022; 20():26-39. PubMed ID: 34976309
[TBL] [Abstract][Full Text] [Related]
38. Detection of Cell Types Contributing to Cancer From Circulating, Cell-Free Methylated DNA.
Barefoot ME; Loyfer N; Kiliti AJ; McDeed AP; Kaplan T; Wellstein A
Front Genet; 2021; 12():671057. PubMed ID: 34386036
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic accuracy of DNA methylation for head and neck cancer varies by sample type and number of markers tested.
Ji X; Guan C; Jiang X; Li H
Oncotarget; 2016 Nov; 7(48):80019-80032. PubMed ID: 27683120
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic Biomarkers in Cell-Free DNA and Applications in Liquid Biopsy.
Gai W; Sun K
Genes (Basel); 2019 Jan; 10(1):. PubMed ID: 30634483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
